By Michele Maatouk
Date: Monday 04 Mar 2024
(Sharecast News) - Renalytix surged on Monday after saying it had received an unsolicited takeover approach from "a large and well-capitalised publicly listed strategic diagnostics company".
By Josh White
Date: Friday 09 Feb 2024
(Sharecast News) - Renalytix shares were rocketing on Friday morning, after it announced that the Centers for Medicare and Medicaid Services (CMS) in the US had published a draft local coverage determination (LCD) for its 'KidneyIntelX' and 'kidneyintelX.dkd' testing products, outlining the coverage and pricing for the tests.
By Josh White
Date: Friday 06 Oct 2023
(Sharecast News) - Diagnostic artificial intelligence (AI) specialist Renalytix announced an enhancement to its intellectual property portfolio for its KidneyIntelX.dkd test on Friday.
Currency | UK Pounds |
Share Price | 16.25p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 145.00 |
52 Week Low | 10.25 |
Volume | 328,498 |
Shares Issued | 154.37m |
Market Cap | £25.08m |
RiskGrade | 348 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:07 | 100,000 @ 16.25p |
16:01 | 5,792 @ 16.21p |
15:55 | 20,000 @ 16.49p |
14:57 | 1,080 @ 16.49p |
10:19 | 100,000 @ 16.45p |
You are here: research